Genetic Screen for Dihydropyridine-Resistant Worms Identifies Key Calcium Channel Residues
Author Information
Author(s): Kwok Trevor C. Y., Hui Kwokyin, Kostelecki Wojciech, Ricker Nicole, Selman Guillermo, Feng Zhong-Ping, Roy Peter John
Primary Institution: University of Toronto
Hypothesis
Can a genetic screen in C. elegans identify new residues important for dihydropyridine sensitivity in calcium channels?
Conclusion
The study identified 30 mutations in the C. elegans calcium channel that affect dihydropyridine sensitivity, suggesting new residues involved in drug interactions.
Supporting Evidence
- The study screened 440,000 C. elegans genomes for DHP resistance.
- 30 missense mutations were identified in the egl-19 gene.
- All characterized mutants exhibited increased channel activity.
- The findings suggest a link between DHP-blockage and voltage-dependent inactivation.
Takeaway
Scientists looked at tiny worms to find out which parts of a calcium channel are important for a type of medicine that helps with heart problems.
Methodology
The researchers screened 440,000 mutated C. elegans genomes for resistance to a new drug called nemadipine and identified mutations in the egl-19 gene.
Limitations
The screen was not done to saturation, and some residues required for DHP sensitivity may remain unidentified.
Participant Demographics
C. elegans (a type of nematode worm)
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website